State of Wisconsin Investment Board’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

State of Wisconsin Investment Board’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-93,683	Closed	-$393K	–	2631
2023 Q1	$393K	Buy	93,683 +1,969	+2%	+$10.2K	﹤0.01%	1969
2022 Q4	$551K	Buy	+91,714	New	+$501K	﹤0.01%	1861
2019 Q2	–	Sell	-68,400	Closed	-$66K	–	1656
2019 Q1	$66K	Buy	68,400 +15,700	+30%	+$16.5K	﹤0.01%	1526
2018 Q4	$39K	Buy	+52,700	New	+$86.6K	﹤0.01%	1532

Other funds holding CTIC

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

State of Wisconsin Investment Board's CTIC Position: Q2 2023 in Review

State of Wisconsin Investment Board sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 93,683 shares — an estimated $393K sold.

State of Wisconsin Investment Board first reported a position in CTIC in Q4 2018 and held it in 4 quarters. The position peaked at $551K in Q4 2022. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.

State of Wisconsin Investment Board reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
State of Wisconsin Investment Board sold 93,683 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2023, an estimated $393K.
State of Wisconsin Investment Board first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q4 2018 and held it in 4 quarters.
State of Wisconsin Investment Board's CTI BioPharma Corp. (DE) Common Stock position peaked at $551K in Q4 2022.
2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2023, filed 14 Aug 2023.